A competitive antagonist of GCGR
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Glucagon Receptor Antagonist I

Item No. 21223

Technical Information
Formal Name
N-[3-cyano-6-(1,1-dimethylpropyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-2-ethyl-butanamide
CAS Number
438618-32-7
Synonyms
  • GCGR Antagonist I
Molecular Formula
C20H30N2OS
Formula Weight
Purity
≥99%
Formulation
A crystalline solid
λmax
216, 252, 260, 304 nm
SMILES
O=C(C(CC)CC)NC(S1)=C(C#N)C2=C1CC(C(C)(C)CC)CC2
InChi Code
InChI=1S/C20H30N2OS/c1-6-13(7-2)18(23)22-19-16(12-21)15-10-9-14(11-17(15)24-19)20(4,5)8-3/h13-14H,6-11H2,1-5H3,(H,22,23)
InChi Key
SWIBDWBSJSJQHL-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Glucagon receptor antagonist I is a competitive antagonist of the glucagon receptor (GCGR; IC50 = 181 nM).1 It blocks glucagon-induced glycogenolysis in primary human hepatocytes and isolated liver.1 Glucagon receptor antagonist I, at 50 mg/kg, reduces the increase in glucose levels observed after intraperitoneal administration of glucagon in humanized mice.1 Glucagon receptor antagonist inactive control (Item No. 21188) does not prevent glucagon-mediated actions.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Qureshi, S.A., Candelore, M.R., Xie, D., et alA novel glucagon receptor antagonist inhibits glucagon-mediated biological effects. Diabetes 53(12), 3267-3273 (2004).